^○Hanaka Mimura¹, Koichi Inoue¹, Akichika Ozeki¹, Yuka Tanji¹, William Kielbasa² (1.Eli Lilly Japan K.K., Kobe, Japan, 2.Eli Lilly and Company, Indianapolis, USA)

^○Kyoko Hosokawa¹, Kiyohide Usami², Yu Tatsuoka¹, Masayuki Honda³, Takefumi Hitomi³, Akihiro Shimotake², Masao Matsuhashi², Daisuke Danno⁴, Takao Takeshima⁴, Yoshihisa Tatsuoka⁵, Ryosuke Takahashi¹, Akio Ikeda² (1.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 2.Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, 3.Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, 4.Department of Neurology, Headache Center, Social Medical Corporation Kotobukikai Tominaga Hospital, 5.Tatsuoka Neurology Clinic)

^○Keisuke Suzuki¹, Shiho Suzuki¹, Yasuo Haruyama², Madoka Okamura¹, Tomohiko Shiina¹, Hiroaki Fujita¹, Gen Kobashi², Koichi Hirata¹ (1.Department of Neurology, Dokkyo Medical University, Japan, 2.Department of Public Health, Dokkyo Medical University School of Medicine)

^○Eiji Kitamura, Naomi Kanazawa, Takahiro Iizuka, Kazutoshi Nishiyama (Kitasato University, School of Medicine, Department of Neurology, Japan)